These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2510347)

  • 1. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
    Otter M; Van Berkel TJ; Rijken DC
    Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
    Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
    Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
    Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
    Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to tissue-type plasminogen activator which prolong its clearance in vivo.
    Reilly TM; Knabb RM; Chiu AT; Bradfute DL; Timmermans PB
    Thromb Haemost; 1989 Apr; 61(2):259-61. PubMed ID: 2546285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated endocytosis of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
    Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1988 Aug; 263(22):10587-94. PubMed ID: 2839497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
    Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of tissue plasminogen activator to cultured human fibroblasts.
    Reilly TM; Whitfield MD; Taylor DS; Timmermans PB
    Thromb Haemost; 1989 Jun; 61(3):454-8. PubMed ID: 2552605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
    Camani C; Gavin O; Kruithof EK
    Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
    Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
    Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of LDL receptor activity in Hep-G2 cells by a serum factor(s).
    Ellsworth JL; Brown C; Cooper AD
    J Cell Physiol; 1988 May; 135(2):213-23. PubMed ID: 2836440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.
    Marks GJ; Hart TK; Rush GF; Hoffstein ST; Fong KL; Bugelski PJ
    Thromb Haemost; 1990 Apr; 63(2):251-8. PubMed ID: 1973006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
    Seydel W; Stang E; Roos N; Krause J
    Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes.
    Wing LR; Bennett B; Booth NA
    FEBS Lett; 1991 Jan; 278(1):95-7. PubMed ID: 1847116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.